The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity. Cent Asian J Med Sci. 2018;4(3):230-237. doi:10.24079/cajms.2018.09.009